Variants of alpha-fetoprotein coding and expression sequences
AssigneeThe University of North Carolina at Chapel Hill
InventorsHiroshi Kubota, Robert Storms, Lola Reid
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of North Carolina at Chapel Hill
InventorsHiroshi Kubota, Robert Storms, Lola Reid
Estimating the term…
The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5′-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin− hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
An isolated nucleic acid having a polynucleotide sequence corresponding to SEQ ID NO:
A nucleic acid primer in which the primer comprises at least ten contiguous nucleotides of a polynucleotide sequence corresponding to SEQ ID NO:
A polypeptide translated from a nucleic acid comprised at least in part by a polynucleotide sequence corresponding to SEQ ID NO:
An isolated nucleic acid having a polynucleotide sequence corresponding to SEQ ID NO:
A nucleic acid primer in which the primer comprises at least ten contiguous nucleotides of a polynucleotide sequence corresponding to SEQ ID NO:
A polypeptide translated from a nucleic acid comprised at least in part by a polynucleotide sequence corresponding to SEQ ID NO:
A composition comprising an isolated nucleic acid having a polynucleotide sequence corresponding to SEQ ID NO:
A polynucleotide primer comprising:
A method of detecting a variant form of alpha-fetoprotein mRNA comprising:
A method of identifying or detecting hemopoietic stem or progenitor cells comprising determining the presence or absence of a variant form of alpha-fetoprotein mRNA in cells suspected of being homopoietic stem or progenitor cells.
An isolated nucleic acid encoding a variant form of alpha-fetoprotein preferentially expressed in progenitor cells, in which exon 1 of exons 1-14 of alpha-fetoprotein has been replaced by a polynucleotide sequence corresponding to SEQ ID NO:
A probe capable of detecting the expression of a variant form of alpha-fetoprotein comprising a nucleic acid consisting essentially of at least 10 contiguous nucleotides of a polynucleotide sequence corresponding to SEQ ID NO:
A method of preparing a subpopulation of cells enriched in hemopoietic progenitors comprising:
A composition comprising at least one subpopulation of cells which comprises hemopoietic progenitors, or their progeny, capable of expressing variant AFP.
Dependencies are inferred from the claim text.